Coya Therapeutics, Inc. COYA
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -49.14%
- 1 year
- -50.67%
Held by funds
11 US ETFs and mutual funds hold COYA · largest positions
Ownership
- Institutions 20.0%
- Insiders 7.03%
- Public and other holders 73.0%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| DME Capital Management, LP | 7.63% | 1,274,026 | 6.77M | Sep 29, 2024 |
| Vanguard Group Inc | 5.06% | 845,424 | 4.49M | Sep 29, 2024 |
| AIGH Capital Management LLC | 3.89% | 649,427 | 3.45M | Sep 29, 2024 |
| CM Management, LLC | 0.86% | 144,059 | 764.95K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.85% | 142,309 | 755.66K | Sep 29, 2024 |
| Blackrock Inc. | 0.39% | 65,826 | 349.54K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.33% | 556,897 | 2.96M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.53% | 256,428 | 1.36M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.44% | 73,529 | 390.44K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.18% | 30,208 | 160.40K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.15% | 24,440 | 129.78K | Oct 30, 2024 |
| Vanguard Balanced Index Fund | 0.10% | 15,974 | 84.82K | Sep 29, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs COYA, and what each was last paid
Arun Swaminathan, Chief Executive Officer & DirectorAverage age 63
| Name | Title | Pay | Age |
|---|---|---|---|
| Arun Swaminathan | Chief Executive Officer & Director | $942K | 57 |
| Fred Grossman FAPA | President & Chief Medical Officer | $787K | 67 |
| David S. Snyder | Chief Financial Officer & Chief Operating Officer | $698K | 66 |
| Michelle Frazier | Senior Vice President of Regulatory | — | — |
| Aaron Thome | Head of Neuroinflammation Platform | — | — |
| Karen King | Senior Vice President of Program Management & Clinical Operations | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERMAN HOWARD | Chief Executive Officer | Purchase | Jan 2, 2023 | 959,338 |
| GARREN HIDEKI | Director | Purchase | Jan 2, 2023 | 2,000 |
| GOLDSTEIN DOV A | Director | Purchase | Jan 2, 2023 | 10,000 |
| GROSSMAN FRED | Officer | Purchase | Nov 10, 2024 | 2,710 |
| HEPNER ADRIAN | Officer | Purchase | Jan 2, 2023 | 10,000 |
| LEE ANN | Director | Purchase | Aug 21, 2023 | 0 |
